
Martin Shkreli
Use attributes for filter ! | |
Gender | Male |
---|---|
Age | 42 |
Date of birth | March 17,1983 |
Zodiac sign | Pisces |
Born | Brooklyn |
New York | |
United States | |
Height | 170 (cm) |
Nationality | American |
Attorney | Benjamin Brafman |
Job | Entrepreneur |
Businessperson | |
Movies/Shows | Pharma Bro |
Education | Baruch College |
Zicklin School of Business | |
Hunter College High School | |
Convict | Securities fraud (2 counts); Conspiracy to commit securities fraud |
securities fraud | |
Crimin penalti | Seven years in prison; $72 million in fines |
Crimin status | Released |
Nominations | NME Award for Villain of the Year |
Date of Reg. | |
Date of Upd. | |
ID | 531971 |
Martin Shkreli Life story
Martin Shkreli is an American CEO, hedge fund manager, and fraud convict. Shkreli is the co-founder of the hedge funds Elea Capital, MSMB Capital Management, and MSMB Healthcare, the co-founder and ...
A one-off Bob Dylan recording could sell for £1m

... That record was initially bought by hedge fund manager Martin Shkreli for an unspecified sum...
Jailed 'Pharma Bro' Martin Shkreli ordered to repay $64m

...Martin Shkreli, the former drug firm executive who ordered dramatic price hikes of a life-saving medicine, has been barred from the industry for life...
Jailed 'Pharma Bro' Martin Shkreli ordered to repay $64m
Martin Shkreli , the former drug firm executive who ordered dramatic price hikes of a life-saving medicine, has been barred from the industry For Life .
In a decision on Friday, Judge Denise Cote ordered him to repay $64. 6m (£47m) in profits he made from the scheme.
She ruled that Mr Shkreli's actions had violated laws against monopolies.
Mr Shkreli is currently serving a prison sentence for defrauding investors.
But this decision is about action he took in 2015 to raise The Price of Daraprim, a long-established medicine used to treat toxoplasmosis, from $13. 50 to $750 - Around 4,000% - Overnight .
He also designed supply agreements to block competitors from offering a generic version of the unpatented medicine, which is used to treat the parasitic disease in pregnant women and patients with Aids.
The moves were unpopular, and earned him the nick-name " Pharma Bro".
Seven states and the Federal Trade Commission brought a lawsuit over the conduct in 2020, saying he had violated state and federal laws that ban anti-competitive conduct.
In her opinion, US District Judge Cote called Mr Shkreli the " prime mover" in the scheme.
" It was his brainchild and he drove it each step of The Way , " she wrote.
Vyera Pharmaceuticals, which Mr Shkreli founded and was previously known as Turing Pharmaceuticals, earlier agreed to pay $40m.
New York Attorney General Letitia James , one of the officials who brought The Suit , celebrated the decision.
She Said Mr Shkreli and his partner had illegally raised the " price of a life-saving drug as Americans' lives hung in the balance".
" But Americans can rest easy because Martin Shkreli is a Pharma Bro no more. "
Source of news: bbc.com